NovaBridge stock: Visara starts ASCEND trial in wet AMD

NovaBridge Biosciences stock gains 10.38 percent on Nasdaq ...
NovaBridge Biosciences stock stood at USD 1.26 on October ...
H.C. Wainwright keeps USD 9.00 target for NovaBridge Biosciences ...
NovaBridge advances givastomig toward Phase III for NovaBridge ...
NovaBridge appoints Martin Dewhurst. NovaBridge stock sits ...
H.C. Wainwright maintains target for NovaBridge Biosciences ...
I-Mab’s Pivotal Year: Clinical Data to Steer Investor ...

I-Mab Initiates Strategic Overhaul with Rebranding and Dual ...